| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.084 | 0.006 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.091 | 0.007 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.007 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.007 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.077 | 0.008 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.009 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.11 | 0.009 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.11 | 0.009 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.13 | 0.009 |